Compare Indo Boga Sukses Tbk. (IBOS) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indo Boga Sukses Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Indo Boga Sukses Tbk. trades at Rp68 (market cap 556.54B, 1.74M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Indo Boga Sukses Tbk. and UBC Medical Indonesia Tbk. are close in size by market cap, and Indo Boga Sukses Tbk. is more actively traded (1.74M versus 817.3K). Which is the better fit depends on your goals.
| IBOS | LABS | |
|---|---|---|
Market Cap | 556.54B | 584.6B |
Volume | 1.74M | 817.3K |
Lot | 17.36K | 8.17K |
Turnover | 120.36M | 120.01M |
Average Price | 69.34 | 146.84 |
Value | 120.36M | 120.01M |
Indicative Equilibrium Price | 68 | 146 |
Indicative Equilibrium Volume | 1.07K | 59 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indo Boga Sukses Tbk.
PT Indo Boga Sukses Tbk (”the Company”) was established based on notarial deed No. 6 dated January 16, 2019 of Tabitha Sri Jeany, S.H, MKn., notary in Yogyakarta.
Read more on IBOS →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
